Weight loss has changed. For the first time, there are medications that work with the body’s own biology to make sustainable weight loss achievable for people who have struggled for years, often through no fault of their own. But with that breakthrough has come a flood of hype, confusion, and misinformation. This guide explains, in plain and honest terms, what GLP-1 medications actually do, what they don’t, and why medical supervision makes such a difference in the results.
Obesity is biology, not willpower
One of the most important shifts in modern medicine is the understanding that excess weight is not simply a matter of discipline. Appetite, cravings, and how the body stores fat are governed by powerful hormonal and genetic systems. For many people, those systems work against weight loss, which is why “eat less, move more” so often fails despite genuine effort. Recognizing obesity as a medical condition, not a personal failing, is the starting point for treating it effectively.
What GLP-1 medications actually are
GLP-1 medications work by mimicking a natural gut hormone, glucagon-like peptide-1, that the body releases after eating. That hormone slows how quickly the stomach empties, prompts the release of insulin when blood sugar is high, and quiets hunger and the constant background “food noise” that drives overeating. The result, for many people, is that eating less no longer feels like a battle of willpower.
Behind the many brand names, there are really two main medications. Semaglutide is sold as Wegovy and Ozempic (and as an oral tablet, Rybelsus), and tirzepatide is sold as Zepbound and Mounjaro. An important distinction: for weight management specifically, the FDA-approved products are Wegovy and Zepbound. Ozempic and Mounjaro contain the same active ingredients but are approved for type 2 diabetes. As of late 2025, semaglutide also became available as a once-daily oral tablet for weight management.
How well do they work?
The results in clinical trials have been significant. In its pivotal trial, semaglutide produced a mean weight loss of about 14.9% of body weight over 68 weeks. Tirzepatide, which activates two hormone receptors rather than one, produced about 20.9% at its highest dose over 72 weeks in its own pivotal trial. More recently, a direct head-to-head trial comparing the two over 72 weeks found tirzepatide produced greater average weight loss (about 20.2%) than semaglutide (about 13.7%). What all of this shows is that both medications can produce results that were simply not achievable with lifestyle changes alone for most people with obesity, and that the right choice between them depends on the individual, not just the averages.
The most important thing to understand
Here is the honest truth that responsible care depends on: these medications treat the biology of appetite while you take them. They do not permanently reset it. When the medication stops, hunger tends to return, and without a plan in place, weight often comes back.
This is not a reason to avoid them. It’s the reason supervision matters so much. GLP-1 medications work best not as a quick fix, but as a tool within a broader, physician-guided plan, one that addresses nutrition, muscle preservation, metabolic health, and a long-term strategy for maintaining results. Used that way, they can be genuinely life-changing. Used in isolation, the results are often temporary.
Why physician supervision changes the outcome
Buying a prescription online and injecting it is not the same as medical weight loss. A physician-supervised program means the medication is one part of comprehensive care. That includes a proper evaluation to confirm the treatment is appropriate and safe for the individual, careful dose titration to manage side effects, attention to preserving muscle mass rather than just losing weight on the scale, monitoring of overall metabolic and cardiovascular health, and, crucially, a plan for what happens over the long term.
Side effects, most commonly nausea and other digestive symptoms, are usually manageable with proper titration and guidance, which is another reason supervision matters. A clinician can adjust the approach to the individual rather than applying a one-size-fits-all protocol.
Weight, hormones, and midlife
For women in midlife, weight is often tangled up with hormonal change. Perimenopause and menopause shift metabolism, body composition, and how the body responds to the same diet and exercise that once worked. This is an area where treating the whole picture, rather than weight in isolation, makes a real difference. Notably, recent Mayo Clinic research found that postmenopausal women on menopausal hormone therapy lost about 35% more weight while taking tirzepatide than those on the medication alone. Because this was an observational study rather than a randomized trial, the researchers were careful to note it shows an association, not proof that hormone therapy caused the added weight loss, but it points to how closely metabolic and hormonal health are connected in midlife.
This intersection, where hormones, metabolism, and weight meet, is central to how Hibiscus approaches care.
A physician-led approach at Hibiscus
At Hibiscus Aesthetics & Wellness, medical weight loss is delivered as comprehensive, physician-supervised care, not simply a prescription. Every plan begins with a thorough evaluation and is tailored to the individual, with attention to the whole picture of metabolic and hormonal health. Dr. Jacinta Anyaoku is board-certified in both Family Medicine and Obesity Medicine, and cares for patients in person in Katy, TX, serving the surrounding West Houston communities including Cinco Ranch, Fulshear, Richmond, and Cypress, as well as virtually across the states where she is licensed.
If you’ve struggled with weight and want an honest, medically sound approach rather than a quick fix, contact us to schedule a consultation and find out what’s right for you.
This article is for general educational purposes and is not medical advice. GLP-1 medications require a medical evaluation to determine whether they are appropriate and safe for you. Always consult a qualified healthcare provider about your individual situation.
This information is not a medical diagnosis. A consultation with Dr. Anyaoku will confirm your treatment options. Individual results may vary.